Latest Imugene (ASX:IMU) News
Page 2
Page 2 of 4
Healthcare Wrap - Week 22 (25 May -> 29 May) 2026
30 May 2026
Imugene Expands Azer-cel Trial with BTKi Combo for Resistant Lymphoma Patients
28 May 2026
Market Wrap - Week 21 (18 May -> 22 May) 2026
23 May 2026
Healthcare Wrap - Week 21 (18 May -> 22 May) 2026
23 May 2026
Imugene’s Azer-cel Posts 81% Response in CAR T-Naïve Blood Cancer Patients
22 May 2026
Market Wrap - Week 12 (16 Mar -> 20 Mar) 2026
21 Mar 2026
Healthcare Wrap - Week 12 (16 Mar -> 20 Mar) 2026
21 Mar 2026
Imugene Unveils $20M Capital Raise to Fuel Azer-cel Clinical Trial Push
17 Mar 2026
Market Wrap - Week 11 (9 Mar -> 13 Mar) 2026
14 Mar 2026
Healthcare Wrap - Week 11 (9 Mar -> 13 Mar) 2026
14 Mar 2026
Imugene Secures $20M to Boost Azer-cel Trials and Restructure Debt
11 Mar 2026
Imugene’s Azer-cel Shows 100% Response in CLL/SLL, Expands Trial with BTKi Combo
10 Mar 2026